Detecting circulating tumor DNA in renal cancer: An open challenge.

[1]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[2]  J. Brugarolas.  Molecular genetics of clear-cell renal cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Bardelli,et al.  Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities. , 2014, Cancer treatment reviews.

[4]  M. Choti,et al.  Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.

[5]  Y. Kukita,et al.  Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data , 2013, PloS one.

[6]  H. Aburatani,et al.  Integrated molecular analysis of clear-cell renal cell carcinoma , 2013, Nature Genetics.

[7]  Holger Moch,et al.  KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics. , 2013, The Journal of molecular diagnostics : JMD.

[8]  Guorong Li,et al.  Quantification of Plasma Cell-Free DNA1 in Predicting Therapeutic Efficacy of Sorafenib on Metastatic Clear Cell Renal Cell Carcinoma , 2013, Disease markers.

[9]  I. Talaat,et al.  Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer , 2012, Journal of clinical laboratory analysis.

[10]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[11]  N. Rosenfeld,et al.  Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA , 2012, Science Translational Medicine.

[12]  Qing Zhang,et al.  The Roles of VHL-Dependent Ubiquitination in Signaling and Cancer , 2012, Front. Oncol..

[13]  H. Moch,et al.  VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations. , 2011, Cancer research.

[14]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[15]  K. Kinzler,et al.  Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.

[16]  K. Jung,et al.  Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[17]  Arianna Di Napoli,et al.  Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. , 2009, Cancer research.

[18]  F. Waldman,et al.  Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors , 2008, Clinical Cancer Research.

[19]  K. Pantel,et al.  Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer , 2008, Annals of the New York Academy of Sciences.

[20]  E. Fasoli,et al.  Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma. , 2008, European journal of cancer.

[21]  M. van Engeland,et al.  Genetics and epigenetics of renal cell cancer. , 2008, Biochimica et biophysica acta.

[22]  G. Sozzi,et al.  Quantitative Analysis of Plasma DNA in Colorectal Cancer Patients , 2006, Annals of the New York Academy of Sciences.

[23]  Frank Diehl,et al.  Detection and quantification of mutations in the plasma of patients with colorectal tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[25]  H. Moch,et al.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.

[26]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[27]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[28]  T. Klatte,et al.  Serum cell‐free DNA in renal cell carcinoma , 2012, Cancer.

[29]  M. Fleischhacker,et al.  Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.